RSVP on Zoom: https://us02web.zoom.us/meeting/register/tZEtfu-przgpHdU99UoFillZ9R10DgarSNMa

NY TECH TALKS
NY Tech Talks showcase incredibly talented founders and leaders in the NY tech community and beyond. Whether we look to fill an auditorium or a fireside setting, we love sitting down with each founder and engaging in a candid and intimate conversation.
We ask founders everything from what inspired them, the ups and downs of their journey as well as questions that enable attendees to know them on a personal level.

The Founder Spotlight, is a series within NY Tech Talks, focused on women founders. We know that women founders receive just 2% of early stage funding; the women at our events have gone against the odds to create transformative tech and dynamic
companies, including ones that support aging parents, use robotics in farming and reimagine the way we educate and prepare students for the future. We celebrate their success and look to them to inspire future women founders.

Katya Sverdlov, CFA, Esq., Co-Founder & CEO, Jelikalite.

On Monday, April 17, at 12 noon ET, we'll welcome Katya Sverdlov for our next founder spotlight! 

About Katya Sverdlov

Katya is a co-founder and CEO of JelikaLite, a biotech company developing non-invasive neurostimulation for children with autism and other neurological conditions. Concurrently, she is a principal of Sverdlov Law PLLC, a boutique law practice focused on estate planning and special needs planning.

Prior to law school, Katya spent twelve years working for several top Wall Street financial companies. Her experience includes progressively senior positions in investment banking and portfolio risk management.

Katya holds a Bachelor of Science degree in Economics from Cornell University. She earned her Juris Doctor from the Brooklyn Law School, graduating Magna Cum Laude. She holds a Chartered Financial Analyst (CFA) designation. In her free time, Katya loves to hike, discuss philosophy at a book club, and explore everything that NYC has to offer with her teenagers. 

About Jelikalite

Autism is a serious developmental disease that lasts a lifetime. The rates of autism continue to rise, the cause of the disease remains unknown and there is no cure. We believe that children on the autism spectrum can lead fulfilling and productive lives. That is why JelikaLite is developing Cognilum, an integrative solution with focus on pediatric neurological health using non-invasive novel therapies. Cognilum will enable children to integrate into society, parents to receive a home-based personalized cost-effective treatment while having a better quality of life, therapists to track progress and efficacy of existing interventions, and both payors and government to spend less money on special education and lifelong residential care. Cognilum may provide benefits that may be difficult to measure with money alone, yet society will bear the ultimate expenses if nothing continues to be done about the millions of children with autism and other neurological disorders who are unable to integrate into society.

RSVP on Zoom: https://us02web.zoom.us/meeting/register/tZEtfu-przgpHdU99UoFillZ9R10DgarSNMa